Eczema-like cutaneous lesions in idiopathic pulmonary fibrosis: a shared Th2-driven pathway?
Abstract
Dear Editor,
Idiopathic pulmonary fibrosis is the most frequent form of idiopathic interstitial pneumonia, characterized by a progressive course and poor prognosis, with a median survival of 3-5 years after diagnosis...
Keywords
Ethics Approval
The study was conducted in accordance with institutional guidelines and approved by the Ethics Committee of Sant’Andrea Hospital, Sapienza University of Rome, Italy (Ethics Committee consent form 273).
References
- Raghu G, Remy-Jardin M, Myers JL, et al. Diagnosis of idiopathic pulmonary fibrosis. an official ATS/ERS/JRS/ALAT clinical practice guideline. Am J Respir Crit Care Med 2018;198:e44-68. DOI: https://doi.org/10.1164/rccm.201807-1255ST
- Harari S, Caminati A. Idiopathic pulmonary fibrosis: from clinical trials to real-life experiences. Eur Respir Rev 2015;24:420-7. DOI: https://doi.org/10.1183/16000617.0042-2015
- Singh P, Guin D, Pattnaik B, Kukreti R. Mapping the genetic architecture of idiopathic pulmonary fibrosis: Meta-analysis and epidemiological evidence of case-control studies. Gene 2024;895:147993. Erratum in: Gene 2025;941:149223. DOI: https://doi.org/10.1016/j.gene.2025.149223
- Drakopanagiotakis F, Wujak L, Wygrecka M, Markart P. Biomarkers in idiopathic pulmonary fibrosis. Matrix Biol 2018;68-69:404-21. DOI: https://doi.org/10.1016/j.matbio.2018.01.023
- Montero P, Milara J, Roger I, Cortijo J. Role of JAK/STAT in interstitial lung diseases; molecular and cellular mechanisms. Int J Mol Sci 2021;22:6211. DOI: https://doi.org/10.3390/ijms22126211
- Mandlik DS, Mandlik SK. Atopic dermatitis: new insight into the etiology, pathogenesis, diagnosis and novel treatment strategies. Immunopharmacol Immunotoxicol 2021;43:105-25. DOI: https://doi.org/10.1080/08923973.2021.1889583
- Galiè N, Humbert M, Vachiery JL, et al. 2015 ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension: the joint task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J 2016;37:67-119. DOI: https://doi.org/10.1093/eurheartj/ehv317
- Hoeper MM, Bogaard HJ, Condliffe R, et al. Definitions and diagnosis of pulmonary hypertension. J Am Coll Cardiol 2013;62:D42-50. DOI: https://doi.org/10.1016/j.jacc.2013.10.032
- McLaughlin VV, Archer SL, Badesch DB, et al. ACCF/AHA 2009 expert consensus document on pulmonary hypertension a report of the American College of Cardiology Foundation task force on expert consensus documents and the American Heart Association developed in collaboration with the American College of Chest Physicians; American Thoracic Society, Inc.; and the Pulmonary Hypertension Association. J Am Coll Cardiol 2009;53:1573-619.
- Thenappan T, Ormiston ML, Ryan JJ, Archer SL. Pulmonary arterial hypertension: pathogenesis and clinical management. BMJ 2018;360:j5492. DOI: https://doi.org/10.1136/bmj.j5492
- Sitbon O, Morrell N. Pathways in pulmonary arterial hypertension: the future is here. Eur Respir Rev 2012;21:321-7. DOI: https://doi.org/10.1183/09059180.00004812
- Dubin C, Del Duca E, Guttman-Yassky E. The IL-4, IL-13 and IL-31 pathways in atopic dermatitis. Expert Rev Clin Immunol 2021;17:835-52. DOI: https://doi.org/10.1080/1744666X.2021.1940962
- Provenzani A, Leonardi Vinci D, Alaimo M, et al. Real-world insights into safety, tolerability, and predictive factors of adverse drug reactions in treating idiopathic pulmonary fibrosis with pirfenidone and nintedanib. Ther Adv Drug Saf 2025;16:20420986251341645. DOI: https://doi.org/10.1177/20420986251341645
Metrics
Citations and online attention from Dimensions, Altmetric and PlumX.
License
Copyright (c) 2026 The Author(s)

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.